Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
August 2028 63
2028-08
Primary completion A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07839936
2028-08
Study completion Bachmann's Bundle Versus Right Atrial Appendage Pacing Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07874763
2028-08-05
Study completion Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07279259
2028-08-07
2028-08-07
2028-08-07
2028-08-08
2028-08-09
2028-08-09
2028-08-09
2028-08-09
2028-08-14
2028-08-14
Study completion PVI Alone Versus PVI Plus PWI and SVCI With PFA Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07405359
2028-08-14
Primary completion PVI Alone Versus PVI Plus PWI and SVCI With PFA Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07405359
2028-08-15
Primary completion Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05556460
2028-08-15
2028-08-17
Primary completion A Study of Cardiovascular Events iN Diabetes Plus Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05441267
2028-08-21
2028-08-23
2028-08-28
Primary completion Digoxin and Senolysis in Heart Failure and Diabetes Mellitus Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06240403
2028-08-28
2028-08-28
2028-08-30
Study completion Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07290699
2028-08-30
2028-08-30
2028-08-30
Study completion A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07691307
2028-08-30
Primary completion A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07691307
2028-08-31
Study completion Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05331144
2028-08-31
2028-08-31
Study completion tACS to Enhance Language Abilities Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06092814
2028-08-31
Primary completion tACS to Enhance Language Abilities Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06092814
2028-08-31
2028-08-31
Primary completion Smart Technologies in Early Post-Stroke Rehabilitation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07171073
2028-08-31
Primary completion Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07273838
2028-08-31
Study completion Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07278531
2028-08-31
Primary completion Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07278531
2028-08-31
2028-08-31
Study completion HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor Management Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07721584
2028-08-31
2028-08-31
Study completion Vortosiran in Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07870889
2028-08-31
September 2028 58
2028-09-01
Primary completion Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03264352
2028-09-01
Study completion Pulmonary Artery Catheter in Cardiogenic Shock Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05485376
2028-09-01
Study completion LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06865885
2028-09-01
Study completion Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07018297
2028-09-01
Primary completion Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07018297
2028-09-01
Primary completion Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07092709
2028-09-01
Primary completion Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07276282
2028-09-01
Primary completion Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors With Statin for ACS Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07736313
2028-09-01
2028-09-01
Primary completion Prevention of Ischemic Stroke Recurrence Using Digital Technology Application Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07825311
2028-09-01
Study completion The OXY-VENT Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07870551
2028-09
Study completion The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02973529
2028-09
2028-09
2028-09
2028-09
Primary completion MLC1501 Study Assessing Efficacy in STROke Recovery Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05046106
2028-09
Primary completion PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05934487
2028-09
Study completion NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06511505
2028-09
2028-09
2028-09
2028-09
Primary completion GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07617155
2028-09
Primary completion A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07642050
2028-09
2028-09
2028-09
Study completion A Trial of CRD-4730 in HFrEF Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07750873
2028-09
Primary completion A Trial of CRD-4730 in HFrEF Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07750873
2028-09
2028-09
2028-09
2028-09
Study completion Continuous Glucose Monitoring and Dietary Self-Management in Adults in Namwon Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07890740
2028-09
2028-09-06
Primary completion Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07866066
2028-09-11
Study completion Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02472028
2028-09-11
Primary completion Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02472028
2028-09-13
Study completion Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04195568
2028-09-15
Study completion The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05095857
2028-09-15
Primary completion The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05095857
2028-09-15
2028-09-15
2028-09-15
2028-09-16
Primary completion Intra-Arterial Thrombolysis After SUCCESSful Reperfusion in Anterior Circulation Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06768138
2028-09-20
Primary completion LAAO Versus NOAC in Patients with AF and PCI Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05353140
2028-09-20
2028-09-25
2028-09-27
2028-09-28
Study completion IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07875179
2028-09-28
Primary completion IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07875179
2028-09-30
Primary completion Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06523959
2028-09-30
Primary completion TAVR vs. SAVR Study of VitaFlow Liberty® for Severe BAV Stenosis Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06597188
2028-09-30
Study completion TENS for Limb Function in Stroke: Design and Rationale for a Randomized Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06997744
2028-09-30
2028-09-30
2028-09-30
2028-09-30
Study completion Sublingual Edaravone Dexborneol for Inter-hospital Transfer Acute Ischemic Stroke (SLEDAIS) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07682922
2028-09-30
Primary completion A Study of BGM0504 in Early T2DM With Obesity Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07743983
2028-09-30
2028-09-30
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2024-05-01
Primary completion Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke Registry record
Expected 2024-05-01; that period ended on 2024-05-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05745311
2024-05-01
Study start Effects of Individualized iTBS on Upper Limb Function After Stroke Registry record
Expected 2024-05-01; that period ended on 2024-05-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06147167
2024-05-01
Study start The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction Registry record
Expected 2024-05-01; that period ended on 2024-05-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06350487
2024-05-01
Study start Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients Registry record
Expected 2024-05-01; that period ended on 2024-05-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06381947
2024-05-03
Study completion Screening of OSA in Hospitalized Stroke Patients Using BSP Registry record
Expected 2024-05-03; that period ended on 2024-05-03.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05466864
2024-05-05
Primary completion Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions Registry record
Expected 2024-05-05; that period ended on 2024-05-05.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04561739
2024-05-15
Primary completion Repository of Phase Signals for Pulmonary Hypertension Algorithm Development Registry record
Expected 2024-05-15; that period ended on 2024-05-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04031989
2024-05-20
Primary completion Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis Registry record
Expected 2024-05-20; that period ended on 2024-05-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05540587
2024-05-24
Primary completion a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency Registry record
Expected 2024-05-24; that period ended on 2024-05-24.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05922436
2024-05-25
Study completion a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency Registry record
Expected 2024-05-25; that period ended on 2024-05-25.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05922436
2024-05-30
Study completion Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic Stenosis Registry record
Expected 2024-05-30; that period ended on 2024-05-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04815785
2024-05-30
Study completion The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery Registry record
Expected 2024-05-30; that period ended on 2024-05-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05006287
2024-05-30
Primary completion The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery Registry record
Expected 2024-05-30; that period ended on 2024-05-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05006287
2024-05
Study completion Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis Registry record
Expected 2024-05; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02657707
2024-05
Primary completion Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease Registry record
Expected 2024-05; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04258397
2024-05-31
Primary completion Spider Versus Emboshield Distal Protection on Cerebral Microembolization During Vulnerable Plaque in Carotid Artery Stenting Registry record
Expected 2024-05-31; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04904250
2024-05-31
Study completion The Flow Diverter for Treating Patients With Intracranial Aneurysms Registry record
Expected 2024-05-31; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05060185
2024-05
Study completion Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease Registry record
Expected 2024-05; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05373004
2024-05
Primary completion A Prospective, Multicenter Study to Evaluate the JensClip Transcatheter Valve Repair System Registry record
Expected 2024-05; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05417945
2024-05-31
Study completion Prophylactic Effects of Agomelatine for Poststroke Depression Registry record
Expected 2024-05-31; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05426304
2024-05-31
Primary completion Prophylactic Effects of Agomelatine for Poststroke Depression Registry record
Expected 2024-05-31; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05426304
2024-05
Study completion Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy Registry record
Expected 2024-05; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05626972
2024-05-31
Primary completion Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin. Registry record
Expected 2024-05-31; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05760456
2024-05-31
Study completion The Effects of Allicor on Patients After Revascularization Treatment During a Year Registry record
Expected 2024-05-31; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05813171
2024-05-31
Study completion Evaluation of the Effectiveness and Safety of ABAStroke Registry record
Expected 2024-05-31; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05979324
2024-05
Primary completion A Study Evaluating the Safety and Efficacy of Neuroprotective Peptide CN-105 Peptide in Patients With Acute Supratentorial Intracerebral Hemorrhage Registry record
Expected 2024-05; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06255977
2024-05
Study start Cardiac Interventional ICE Imaging Trial Registry record
Expected 2024-05; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06344494
2024-05
Study start Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for Coronary Small Vessels Registry record
Expected 2024-05; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06345209
2024-05
Study start Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke Registry record
Expected 2024-05; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06374823
2024-05-31
Study start Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients Registry record
Expected 2024-05-31; that period ended on 2024-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06417489
2024-06-01
Study completion Lovastatin for Treatment of Brain Arteriovenous Malformations Registry record
Expected 2024-06-01; that period ended on 2024-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04297033
2024-06-01
Primary completion Lovastatin for Treatment of Brain Arteriovenous Malformations Registry record
Expected 2024-06-01; that period ended on 2024-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04297033
2024-06-01
Study completion Landiolol for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery Registry record
Expected 2024-06-01; that period ended on 2024-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05084118
2024-06-01
Primary completion Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Lower Extremity Arteriosclerosis Occlusive Lumen Registry record
Expected 2024-06-01; that period ended on 2024-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05625711
2024-06-01
Study completion Follow up of Clinical Outcome of Deferred vs Immediate Stenting in High Thrombus Stemi Patients Registry record
Expected 2024-06-01; that period ended on 2024-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05793671
2024-06-01
Study start METFORMIN FOR ATRIAL FIBRILLATION Registry record
Expected 2024-06-01; that period ended on 2024-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05878535
2024-06-01
2024-06-01
Primary completion Three Dimensional Navigation IntraCardiac Guidance Kit for Atrial Septal Puncture Registry record
Expected 2024-06-01; that period ended on 2024-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06188351
2024-06-01
Study start TEC4Home Blood Pressure Randomized Controlled Trial Registry record
Expected 2024-06-01; that period ended on 2024-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06303206
2024-06-01
Study start Clinical Effects of Intra-aortic Balloon Support in Early Acute Coronary Syndrome and Non-Acute Coronary Syndrome Related Cardiogenic Shock Registry record
Expected 2024-06-01; that period ended on 2024-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06414187
2024-06-07
Primary completion Dapagliflozin Evaluation on Atrial Fibrillation Patients Followed Cox Maze IV Procedure Registry record
Expected 2024-06-07; that period ended on 2024-06-07.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05816733
2024-06-12
2024-06-12
Study completion EMpagliflozin to PREvent worSening of Left Ventricular Volumes and Systolic Function After Myocardial Infarction Registry record
Expected 2024-06-12; that period ended on 2024-06-12.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05020704
2024-06-12
Primary completion EMpagliflozin to PREvent worSening of Left Ventricular Volumes and Systolic Function After Myocardial Infarction Registry record
Expected 2024-06-12; that period ended on 2024-06-12.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05020704
2024-06-15
2024-06-24
Study completion Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension Registry record
Expected 2024-06-24; that period ended on 2024-06-24.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04474899
2024-06
Study completion Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS) Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01650792
2024-06
Primary completion Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS) Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01650792
2024-06
Study completion Trial for MicroPort's Firesorb BVS: FUTURE-III Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03660202
2024-06
Study completion PIONEER Trial:Hemodynamic Support With ECMO and IABP in Elective Complex High-risk PCI Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04045873
2024-06-30
Primary completion ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction Registry record
Expected 2024-06-30; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04476173
2024-06
Study completion Magnesium Treating Subarachnoid Hemorrhage Vasospasm Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04613960
2024-06-30
Primary completion Genotype-guided Strategy for Antithrombotic Treatment in Peripheral Arterial Disease. Registry record
Expected 2024-06-30; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04619927
2024-06-30
Study completion Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome Registry record
Expected 2024-06-30; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04718025
2024-06-30
Primary completion Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome Registry record
Expected 2024-06-30; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04718025
2024-06-30
Study completion Investigational Study of Delayed Release Metformin Registry record
Expected 2024-06-30; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04854512
2024-06-30
Primary completion Hemodynamic Optimization of Cerebral Perfusion After Endovascular Therapy in Patients With Acute Ischemic Stroke Registry record
Expected 2024-06-30; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04892511
2024-06
Study completion Rotablation vs Intravascular Lithotripsy in Calcified Coronary Lesions Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04960319
2024-06-30
Study completion Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction Registry record
Expected 2024-06-30; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04984954
2024-06
Primary completion Valveclip® Transcatheter Mitral Valve Repair Study Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05021614
2024-06
Primary completion Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05041010
2024-06-30
Primary completion Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D Registry record
Expected 2024-06-30; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05140694
2024-06
Study completion Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05294887
2024-06
Primary completion Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05294887
2024-06-30
Study completion The Multicenter Clinical Trial of a Novel TEER Decive (V-CLASP Trial) Registry record
Expected 2024-06-30; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05391802
2024-06-30
Study completion Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone Dexborneol Registry record
Expected 2024-06-30; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06248242
2024-06-30
Primary completion Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone Dexborneol Registry record
Expected 2024-06-30; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06248242
2024-06
Study start Advapro Coronary Stent System in Coronary Artery Diseased Patients. Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06300268
2024-06
Study completion Oral Enteral Nutrition Tube Feeding on Stroke Survivors Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06301646
2024-06
Primary completion Oral Enteral Nutrition Tube Feeding on Stroke Survivors Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06301646
2024-06
Study start SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06442280
2024-06
Study start Henagliflozin's Impact on Prediabetes Remission Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06448130
2024-06
Study start Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD Registry record
Expected 2024-06; that period ended on 2024-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06449833
2024-07-01
Study start Quelling of Excitotoxicity in Acute Stroke With Ketamine Registry record
Expected 2024-07-01; that period ended on 2024-07-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03223220
2024-07-01
Primary completion Diabetes Discharge Transitional CGM Study (DDT-CGM) Registry record
Expected 2024-07-01; that period ended on 2024-07-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04729985
2024-07-01
Study completion Effects of Individualized Accurate Positioning TMS Based on Task fMRI Activation on Upper Extremity Function After Stroke Registry record
Expected 2024-07-01; that period ended on 2024-07-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05440292
2024-07-01
Primary completion Effects of Individualized Accurate Positioning TMS Based on Task fMRI Activation on Upper Extremity Function After Stroke Registry record
Expected 2024-07-01; that period ended on 2024-07-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05440292
2024-07-01
Study completion The Safety and Efficacy of Embotrap in Treating Acute Ischemic Stroke Patients Registry record
Expected 2024-07-01; that period ended on 2024-07-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05667103
2024-07-01
Primary completion The Safety and Efficacy of Embotrap in Treating Acute Ischemic Stroke Patients Registry record
Expected 2024-07-01; that period ended on 2024-07-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05667103
2024-07-01
Study completion Medical Monitoring of Older Adults Patients After Discharged From Heart Failure Hospitalization Registry record
Expected 2024-07-01; that period ended on 2024-07-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06018532
2024-07-01
Study start Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis Registry record
Expected 2024-07-01; that period ended on 2024-07-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06243133
2024-07-01
Study start REstoration of VItamin D in Pulmonary Arterial Hypertension Registry record
Expected 2024-07-01; that period ended on 2024-07-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06258850
2024-07-01
Study start Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions Registry record
Expected 2024-07-01; that period ended on 2024-07-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06441539
2024-07-01
Study start Reducing Salt and Sugar in Campus Foods: A Malaysian Study Registry record
Expected 2024-07-01; that period ended on 2024-07-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06473038
2024-07-20
Study completion A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus Registry record
Expected 2024-07-20; that period ended on 2024-07-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06256549
2024-07-20
Primary completion A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus Registry record
Expected 2024-07-20; that period ended on 2024-07-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06256549
2024-07-30
Study completion Cryoballoon Isolation of Superior Vena Cava in Paroxysmal Atrial Fibrillation Registry record
Expected 2024-07-30; that period ended on 2024-07-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05081310
2024-07-30
Primary completion Cryoballoon Isolation of Superior Vena Cava in Paroxysmal Atrial Fibrillation Registry record
Expected 2024-07-30; that period ended on 2024-07-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05081310
2024-07-30
Study completion Effect of Multielectrode Versus Point-by-Point Mapping on Recurrence of Ventricular Tachycardia in Ischemic Heart Disease Registry record
Expected 2024-07-30; that period ended on 2024-07-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05203484
2024-07-30
Study completion Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke Registry record
Expected 2024-07-30; that period ended on 2024-07-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05745311
2024-07
2024-07
Study completion Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis Registry record
Expected 2024-07; that period ended on 2024-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04982367
2024-07
Primary completion Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis Registry record
Expected 2024-07; that period ended on 2024-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04982367
2024-07
Study completion ThrombX Retriever for Acute Ischemic Stroke Trial Registry record
Expected 2024-07; that period ended on 2024-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05270122
2024-07-31
Study completion Evaluation of a Digital Care System in the Follow-Up Care of Atrial Fibrillation Patients Registry record
Expected 2024-07-31; that period ended on 2024-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05375877
2024-07
2024-07
2024-07
2024-07-31
Primary completion Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR) Registry record
Expected 2024-07-31; that period ended on 2024-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06101888
2024-07
Primary completion Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia Registry record
Expected 2024-07; that period ended on 2024-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06153433